NC State Health Director Standing Orders

House Bill 96 Standing Orders - SL 2021-110

• Nicotine replacement therapy that is approved by the United States Food and Drug Administration
  • Standing Order for Nicotine Replacement Therapy March 24, 2022
  • Nicotine Replacement Therapy Documentation & Communication Form
• Self-administered oral or transdermal contraceptives
  • Hormonal Contraceptive Standing Order – Signed March 2022
  • Patient Documentation Communication Form – March 2022
• Prenatal vitamins
  • Standing Order for Multivitamins with Folic Acid March 2022
• Post-exposure prophylaxis medications for the prevention of human immunodeficiency virus (HIV)
  • Standing Order for Post-exposure prophylaxis (PEP) for the prevention of HIV
  • PEP Patient Questionnaire
  • PEP Documentation and Communication Form
• Glucagon for the treatment of severe hypoglycemia
  • Standing orders for Glucagon

COVID-19 Related Standing Orders

Vaccine

• Statewide Standing Order for Pfizer-BioNTech mRNA COVID-19 Vaccine Administration in Patients Ages 5-11 Years (May 20, 2022)
• Statewide Standing Order for Pfizer/COMIRNATY COVID-19 Vaccine Administration in Patients Ages 12 Years and Older (March 31, 2022)
• Statewide Standing Order for Janssen COVID-19 Vaccine Administration (February 15, 2022)
• Statewide Standing Order for Moderna COVID-19 Vaccine Administration (April 7, 2022)

Therapeutics

• Sotrovimab
• Bebtelovimab

Testing

• Statewide Standing Order for COVID-19 Diagnostic Testing (Jan. 5, 2022)
• Statewide Standing Order to Allow Pharmacists to Dispense Over the Counter At-Home COVID-19 Tests (Jan. 14, 2022)

Naloxone Standing Orders

• North Carolina’s Standing Order for Naloxone
• List of Approved Products for Pharmacist Dispensing

Last Modified: 05-24-2022